For more than 15 million people, taking a 23andMe test once seemed like a good idea.  For around 80% of customers, their interaction with the company went even further—they opted to have their data used in health research.

23andMe, the company whose mail-in self-testing kits became synonymous with DNA testing, is filing for bankruptcy . Anne Wojcicki, who co-founded 23andMe in 2006, is stepping down as CEO as the company tries to find a buyer amid slowing sales four years after going public.

As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of American consumers who have used the Company's genetic testing and telehealth services.

Following the firm’s bankruptcy, researchers hope that they will be able to continue accessing the valuable data set even if it is sold to new owners.

Genetic testing service 23andMe has filed for Chapter 11 bankruptcy protection to keep the company running while reorganizing its debts.

The bankruptcy filing of 23andMe has sparked the potential for a sale that could be used to solve cold cases with the use of genetic testing.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' genetic information up for sale.

Me has filed for bankruptcy, prompting people who've used the service and sent in DNA samples to be analyzed to wonder what will happen to their genetic data.

Me, one of the first companies to provide direct-to-consumer genetic testing kits, has filed for bankruptcy. Since its founding in 2006, it has sold over 12 million DNA kits, with high-profile users including Oprah Winfrey and Warren Buffett.